These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 35354308)

  • 1. Macrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis Development.
    Zhang J; Zhao X; Guo Y; Liu Z; Wei S; Yuan Q; Shang H; Sang W; Cui S; Xu T; Yang K; Guo J; Pan C; Wang J; Pang J; Han T; Chen Y; Xu F
    Arterioscler Thromb Vasc Biol; 2022 Jun; 42(6):700-716. PubMed ID: 35354308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALDH2 deficiency augments atherosclerosis through the USP14-cGAS-dependent polarization of proinflammatory macrophages.
    Rui H; Yu H; Chi K; Han Z; Zhu W; Zhang J; Guo H; Zou W; Wang F; Xu P; Zou D; Song X; Liu L; Wu X; Wu W; Qin D; Cao Y; Xu F; Xue L; Chen Y
    Redox Biol; 2024 Oct; 76():103318. PubMed ID: 39178733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldehyde dehydrogenase 2 deficiency promotes atherosclerotic plaque instability through accelerating mitochondrial ROS-mediated vascular smooth muscle cell senescence.
    Zhu H; Wang Z; Dong Z; Wang C; Cao Q; Fan F; Zhao J; Liu X; Yuan M; Sun X; Peng X; Zou Y; Zhou J; Ge J; Zhou X; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1782-1792. PubMed ID: 30315930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
    Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic Lesions by Impairing Efferocytosis.
    Seneviratne AN; Edsfeldt A; Cole JE; Kassiteridi C; Swart M; Park I; Green P; Khoyratty T; Saliba D; Goddard ME; Sansom SN; Goncalves I; Krams R; Udalova IA; Monaco C
    Circulation; 2017 Sep; 136(12):1140-1154. PubMed ID: 28698173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldehyde dehydrogenase 2 inhibits inflammatory response and regulates atherosclerotic plaque.
    Pan C; Xing JH; Zhang C; Zhang YM; Zhang LT; Wei SJ; Zhang MX; Wang XP; Yuan QH; Xue L; Wang JL; Cui ZQ; Zhang Y; Xu F; Chen YG
    Oncotarget; 2016 Jun; 7(24):35562-35576. PubMed ID: 27191745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-specific deletion of MIC26 (APOO) mitigates advanced atherosclerosis by increasing efferocytosis.
    Tang X; Huang Z; Wang F; Chen J; Qin D; Peng D; Yu B
    Atherosclerosis; 2023 Dec; 386():117374. PubMed ID: 37995600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetaldehyde dehydrogenase 2 interactions with LDLR and AMPK regulate foam cell formation.
    Zhong S; Li L; Zhang YL; Zhang L; Lu J; Guo S; Liang N; Ge J; Zhu M; Tao Y; Wu YC; Yin H
    J Clin Invest; 2019 Jan; 129(1):252-267. PubMed ID: 30375985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huanglian Jiedu Decoction enhances the stability of atherosclerotic plaques through SLC2A1-mediated efferocytosis.
    Zhou G; Lin L; Wang S; Dong M; Lu K; Zhang Y; Lin Z; Lin J; Wu W; Peng R; Luo C
    Int Immunopharmacol; 2024 Oct; 140():112834. PubMed ID: 39116495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD147 Sparks Atherosclerosis by Driving M1 Phenotype and Impairing Efferocytosis.
    Lv JJ; Wang H; Zhang C; Zhang TJ; Wei HL; Liu ZK; Ma YH; Yang Z; He Q; Wang LJ; Duan LL; Chen ZN; Bian H
    Circ Res; 2024 Jan; 134(2):165-185. PubMed ID: 38166463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis.
    Yamamoto S; Yancey PG; Zuo Y; Ma LJ; Kaseda R; Fogo AB; Ichikawa I; Linton MF; Fazio S; Kon V
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2856-64. PubMed ID: 21979434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency.
    Wang M; Subramanian M; Abramowicz S; Murphy AJ; Gonen A; Witztum J; Welch C; Tabas I; Westerterp M; Tall AR
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):976-84. PubMed ID: 24651678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Tyrosine Phosphatase SHP2 in Macrophages Acts as an Antiatherosclerotic Regulator in Mice.
    Wu C; Zheng P; Ma L; Xu C; Hu L; Yang Z; Fei F; Shen Z; Zhang X; Wu Z; Cheng H; Mao W; Ke Y
    Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):202-217. PubMed ID: 37942607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice.
    Stachowicz A; Olszanecki R; Suski M; Wiśniewska A; Totoń-Żurańska J; Madej J; Jawień J; Białas M; Okoń K; Gajda M; Głombik K; Basta-Kaim A; Korbut R
    J Am Heart Assoc; 2014 Nov; 3(6):e001329. PubMed ID: 25392542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 Controls Circadian Regulation of Apoptosis in Atherosclerotic Lesions.
    Schober A; Blay RM; Saboor Maleki S; Zahedi F; Winklmaier AE; Kakar MY; Baatsch IM; Zhu M; Geißler C; Fusco AE; Eberlein A; Li N; Megens RTA; Banafsche R; Kumbrink J; Weber C; Nazari-Jahantigh M
    Circulation; 2021 Sep; 144(13):1059-1073. PubMed ID: 34233454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoproteasome subunit β5i regulates diet-induced atherosclerosis through altering MERTK-mediated efferocytosis in Apoe knockout mice.
    Liao J; Xie Y; Lin Q; Yang X; An X; Xia Y; Du J; Wang F; Li HH
    J Pathol; 2020 Mar; 250(3):275-287. PubMed ID: 31758542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage Interleukin-1β Production.
    Ceneri N; Zhao L; Young BD; Healy A; Coskun S; Vasavada H; Yarovinsky TO; Ike K; Pardi R; Qin L; Qin L; Tellides G; Hirschi K; Meadows J; Soufer R; Chun HJ; Sadeghi MM; Bender JR; Morrison AR
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):328-340. PubMed ID: 27834690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.
    Yu P; Qian AS; Chathely KM; Trigatti BL
    Atherosclerosis; 2018 Sep; 276():171-181. PubMed ID: 29853191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIM25-mediated XRCC1 ubiquitination accelerates atherosclerosis by inducing macrophage M1 polarization and programmed death.
    Wu H; Gao W; Ma Y; Zhong X; Qian J; Huang D; Ge J
    Inflamm Res; 2024 Sep; 73(9):1445-1458. PubMed ID: 38896288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis.
    Tao H; Yancey PG; Babaev VR; Blakemore JL; Zhang Y; Ding L; Fazio S; Linton MF
    J Lipid Res; 2015 Aug; 56(8):1449-60. PubMed ID: 26059978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.